PEAK6 Group’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-12,392
Closed -$1.22M 4439
2017
Q4
$1.22M Buy
12,392
+12,383
+137,589% +$1.17M 0.01% 1768
2017
Q3
$1K Sell
9
-9,930
-100% -$1.05M ﹤0.01% 4298
2017
Q2
$1.1M Buy
9,939
+9,457
+1,962% +$1,000K 0.01% 1853
2017
Q1
$47K Buy
+482
New +$45.9K ﹤0.01% 3863
2015
Q4
Sell
-17,760
Closed -$1.19M 4855
2015
Q3
$1.09M Buy
+17,760
New +$1.24M 0.01% 2111
2014
Q2
Sell
-2,130
Closed -$125K 4689
2014
Q1
$123K Sell
2,130
-1,541
-42% -$82.6K ﹤0.01% 3781
2013
Q4
$196K Buy
3,671
+71
+2% +$4.21K ﹤0.01% 3529
2013
Q3
$111K Buy
3,600
+2,400
+200% +$144K ﹤0.01% 4126
2013
Q2
$73 Buy
+1,200
New +$71.5K ﹤0.01% 4262

Other funds holding DGX

PEAK6 Group's DGX Position: Q1 2018 in Review

PEAK6 Group sold out of Quest Diagnostics (DGX) in Q1 2018, closing a stake of 12,392 shares — an estimated $1.22M sold.

PEAK6 Group first reported a position in DGX in Q2 2013 and held it in 9 quarters. The position peaked at $1.22M in Q4 2017. 652 funds tracked by Wall St. Rank hold DGX as of Q1 2018.

  • PEAK6 Group reported no remaining Quest Diagnostics position as of Q1 2018 after selling out during the quarter.
  • PEAK6 Group sold 12,392 Quest Diagnostics shares in Q1 2018, an estimated $1.22M.
  • PEAK6 Group first reported a position in Quest Diagnostics in Q2 2013 and held it in 9 quarters.
  • PEAK6 Group's Quest Diagnostics position peaked at $1.22M in Q4 2017.
  • 652 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2018.

Based on PEAK6 Group's 13F filing for Q1 2018, filed 15 May 2018.